Back to Directory
Ganirelix
Performance & EnduranceGnRH antagonist for IVF, prevents premature LH surge during ovarian stimulation.
Key Benefits
- ✓Prevents premature ovulation in IVF
- ✓No flare effect
- ✓Immediate suppression
- ✓Shorter IVF protocols
- ✓Flexible start options
Dosing Information
Dosage Range
250 mcg
Frequency
Once daily
Typical Duration
5-7 days during IVF
Detailed Protocol
Administered via subcutaneous injection daily during mid-to-late follicular phase of IVF cycle. Continued until hCG trigger given. Medical use only.
About Ganirelix
Ganirelix (Orgalutran) is a synthetic decapeptide GnRH antagonist used during controlled ovarian hyperstimulation for IVF. It suppresses premature LH surges without the initial stimulatory flare seen with GnRH agonists.
Research Notes
FDA-approved for IVF protocols. Clinical trials show effective prevention of premature LH surge. Allows more flexible IVF protocols than agonist approaches.
Potential Side Effects
- •Injection site reactions
- •Abdominal pain
- •Headache
- •OHSS risk
Always consult with a healthcare professional before starting any peptide therapy.